Gemstone Capital promotes Kristoffer Lippert

Copenhagen, January 1 2021 Gemstone Capital promotes Kristoffer Lippert to Associate Director and opens up for new career opportunities. We are happy to announce that as of January 1st, 2022, Kristoffer is promoted to Associate Director at Gemstone Capital. Kristoffer joined the Gemstone team in the fall of 2020 as Project Manager. From day one,…

2021: Pre-IPO funding in numbers

December 2021: 4.6mDKK Pre-IPO funding for life-science company DK life-science company [name undisclosed] with unique platform technology closes a pre-IPO round, as a last step prior to an anticipated IPO in 2022. Gemstone acts as the Company’s financial advisor, and facilitated the process and transaction. June 2021: 10.2mDKK pre-IPO convertible loan for Brain+ Brain+ closes…

Brain+ lands partnership with Roche

Copenhagen, December 2021 Brain+ lands partnership with Roche for entry in Germany 2 years ahead of plan. “Brain+ has signed a partnership agreement with RoX Health (https://roxhealth.com/), a subsidiary of the global pharma company Roche in Germany, to bring its first dementia products to the German market.” Read more about the partnership HERE.   Brain+…

Expres2ion Biotechnologies announces positive results for its breast cancer vaccine

Copenhagen, December 2021 “ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion”) announces that its capsid virus-like particle (cVLP) breast cancer vaccine candidate ES2B-C001 demonstrated strong tumor-growth inhibiting effect in a mice model, thus reaching an important pre-clinical milestone ahead of schedule.” Read more about the exciting news HERE. Expres2ion was Gemstone Capital’s first IPO…